data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
CymaBay Therapeutics
(NASDAQ:CBAY)
$2.77
-0.18[-6.10%]
At close: Jul 1
$2.77
00
After Hours: 4:30PM EDT
Day High/Low2.77 - 2.98
52 Week High/Low1.67 - 4.74
Open / Close2.94 / 2.77
Float / Outstanding71.6M / 84.7M
Vol / Avg.387.3K / 769.3K
Mkt Cap234.6M
P/E-
50d Avg. Price2.18
Div / Yield-
Payout Ratio-
EPS-0.32
Total Float71.6M

CymaBay Therapeutics (NASDAQ:CBAY), Quotes and News Summary

CymaBay Therapeutics (NASDAQ: CBAY)

Day High/Low2.77 - 2.98
52 Week High/Low1.67 - 4.74
Open / Close2.94 / 2.77
Float / Outstanding71.6M / 84.7M
Vol / Avg.387.3K / 769.3K
Mkt Cap234.6M
P/E-
50d Avg. Price2.18
Div / Yield-
Payout Ratio-
EPS-0.32
Total Float71.6M
Benzinga - Jun 23, 2022, 4:25AM
Benzinga - Jun 22, 2022, 8:08AM
Benzinga - May 23, 2022, 12:43PM
Benzinga - May 23, 2022, 8:06AM
Benzinga - May 18, 2022, 9:41AM
Benzinga - May 16, 2022, 7:41AM
Benzinga - May 12, 2022, 5:27PM
Benzinga - Apr 4, 2022, 8:11AM
Benzinga - Mar 17, 2022, 4:48PM
Benzinga - Mar 17, 2022, 4:07PM
load more
Sector: Health Care.Industry: Pharmaceuticals
CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral, G-protein coupled receptor agonist being evaluated as a therapeutic agent for patients with Type 2 diabetes and MBX-8025 is a selective agonist for the peroxisome proliferator-activated receptor delta.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.310-0.320 -0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

CymaBay Therapeutics Questions & Answers

Q
How do I buy CymaBay Therapeutics (CBAY) stock?
A

You can purchase shares of CymaBay Therapeutics (NASDAQ: CBAY) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are CymaBay Therapeutics's (CBAY) competitors?
Q
What is the target price for CymaBay Therapeutics (CBAY) stock?
A

The latest price target for CymaBay Therapeutics (NASDAQ: CBAY) was reported by B. Riley Securities on Wednesday, May 18, 2022. The analyst firm set a price target for 8.00 expecting CBAY to rise to within 12 months (a possible 188.81% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for CymaBay Therapeutics (CBAY)?
A

The stock price for CymaBay Therapeutics (NASDAQ: CBAY) is $2.77 last updated July 1, 2022, 8:00 PM UTC.

Q
Does CymaBay Therapeutics (CBAY) pay a dividend?
A

There are no upcoming dividends for CymaBay Therapeutics.

Q
When is CymaBay Therapeutics (NASDAQ:CBAY) reporting earnings?
A

CymaBay Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is CymaBay Therapeutics (CBAY) going to split?
A

There is no upcoming split for CymaBay Therapeutics.

Q
What sector and industry does CymaBay Therapeutics (CBAY) operate in?
A

CymaBay Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.